MA
60
5
SLG
37
6
DLTR
52
8
IR
46
3
GD
42
4
DNB
72
4
CMA
42
3
BDX
59
3
EIX
61
8
MET
58
2
TXN
29
4
VIX
41
-11
GWW
50
9
CMCSA
49
3
FSLR
50
6
WFC
58
8
AIZ
61
5
HUM
25
4
LEG
16
2
STT
48
4
MA
60
5
SLG
37
6
DLTR
52
8
IR
46
3
GD
42
4
DNB
72
4
CMA
42
3
BDX
59
3
EIX
61
8
MET
58
2
TXN
29
4
VIX
41
-11
GWW
50
9
CMCSA
49
3
FSLR
50
6
WFC
58
8
AIZ
61
5
HUM
25
4
LEG
16
2
STT
48
4
Financhill
Back

Corcept Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
62

CORT
Corcept Therapeutics

Last Price:
$51.46
Seasonality Move:
11.1%
Sell
27

ALNY
Alnylam Pharmaceuticals

Last Price:
$245.56
Seasonality Move:
2.78%
Buy
62
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics a Buy, Sell or Hold?

  • The current Corcept Therapeutics [CORT] share price is $51.43. The Score for CORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $245.50. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

  • The Corcept Therapeutics share price today is $51.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $245.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 37.6 Sell
Chaikin Money Flow: 513952 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.71 - 59.69) Sell
Bollinger Bands (100): (36.75 - 54.85) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.01 Sell
Relative Strength Index (14 RSI): 43.61 Sell
Chaikin Money Flow: 935904 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (240.56 - 254.54) Sell
Bollinger Bands (100): (251.01 - 281.19) Sell

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.67 Sell
20-day SMA: 57.34 Sell
50-day SMA: 53.53 Sell
200-day SMA: 36.92 Buy
8-day EMA: 54.09 Sell
20-day EMA: 55.57 Sell
50-day EMA: 52.97 Sell
200-day EMA: 40.7 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 244.71 Buy
20-day SMA: 249.56 Sell
50-day SMA: 264.07 Sell
200-day SMA: 220.46 Buy
8-day EMA: 244.75 Buy
20-day EMA: 249.26 Sell
50-day EMA: 256.57 Sell
200-day EMA: 234.24 Buy

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.32 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.

Corcept Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):